Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
38 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07761351 | A Randomized Controlled Trial Comparing Percutaneous CT-Guided Biopsy and Shape-Sensing Robotic-Assisted Bronchoscopy(ENCOMPASS) | recruiting | Phase 4 | 550 | Intuitive SurgicalINDUSTRY | 3 | Sep 25, 2026 | clinicaltrials |
| NCT01742299 | Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator | completed | Phase 4 | 155 | Novartis PharmaceuticalsINDUSTRY | 11 |
| Aug 18, 2026 |
| clinicaltrials |
| NCT05088876 | Paracetamol in Addition to WHO Step III Opioids in Chronic Cancer Pain Control(ParOP) | terminated | Phase 4 | 7 | Insel Gruppe AG, University Hospital BernOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT06717919 | HOPE Against Cancer Recurrence in HCC(HOPE4Cancer) | recruiting | Phase 4 | 220 | Philipp DutkowskiOTHER | 17 | Dec 16, 2025 | clinicaltrials |
| NCT07045935 | Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment(ProBOLIC) | recruiting | Phase 4 | 60 | University Hospital, Basel, SwitzerlandOTHER | 1 | Sep 23, 2025 | clinicaltrials |
| NCT04362072 | Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer | completed | Phase 4 | 71 | PfizerINDUSTRY | 7 | Jun 11, 2025 | clinicaltrials |
| NCT05362760 | Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management(MINERVA) | recruiting | Phase 4 | 300 | Prof. Wolfgang JanniOTHER | 2 | May 16, 2025 | clinicaltrials |
| NCT06408688 | Safety and Modulation of Adaptive Immunity by Iscador® Qu Viscum Album Extract in Patients With Advanced, Recurrent or Metastatic Cancers Treated With Immune Checkpoint Inhibitors(ISCA-CHECK) | recruiting | Phase 4 | 100 | University Hospital, Basel, SwitzerlandOTHER | 1 | Dec 27, 2024 | clinicaltrials |
| NCT04078152 | Durvalumab Long-Term Safety and Efficacy Study(WAVE) | completed | Phase 4 | 163 | AstraZenecaINDUSTRY | 31 | Dec 20, 2024 | clinicaltrials |
| NCT01794793 | Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies | completed | Phase 4 | 337 | RECORDATI GROUPINDUSTRY | 28 | Oct 1, 2024 | clinicaltrials |
| NCT06293677 | Adjustment of Antibiotic Dosage in Pediatric Oncology Patients With Febrile Neutropenia and Augmented Renal Clearance(DAR-ARC) | unknown | Phase 4 | 30 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Jul 11, 2024 | clinicaltrials |
| NCT02869789 | An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers | completed | Phase 4 | 1,041 | Bristol-Myers SquibbINDUSTRY | 21 | Jun 15, 2023 | clinicaltrials |
| NCT01770340 | Nerve Grafting With an Allograft During Radical Prostatectomy - Extended Follow-up in a Prospective Randomized Trial | terminated | Phase 4 | 30 | Kantonsspital Winterthur KSWOTHER | 1 | Feb 21, 2021 | clinicaltrials |
| NCT02005770 | Anesthesia and Circulating Tumor Cells in Breast Cancer | completed | Phase 4 | 221 | University of ZurichOTHER | 1 | Apr 14, 2020 | clinicaltrials |
| NCT02335151 | CTC Pancreatic Adenocarcinoma | completed | Phase 4 | 86 | University of ZurichOTHER | 1 | Dec 13, 2019 | clinicaltrials |
| NCT02670564 | ALL SCTped FORUM - Pharmacogenomic Study (add-on Study) | unknown | Phase 4 | 1,000 | Swiss Pediatric Oncology GroupOTHER | 1 | Apr 16, 2019 | clinicaltrials |
| NCT00488384 | Acitretin Plasma Levels Under Hemodialysis | withdrawn | Phase 4 | 0 | Günther HofbauerOTHER | 1 | Jul 19, 2018 | clinicaltrials |
| NCT01552291 | The Impact of Preoperative Oral Glutamine Intake on the Immunocompetence and Outcomes of Malnourished Patients Undergoing Major Abdominal Surgery Due to Malignancies(Glutaminprojec) | completed | Phase 4 | 42 | Insel Gruppe AG, University Hospital BernOTHER | 1 | Feb 13, 2018 | clinicaltrials |
| NCT00430352 | MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma. | completed | Phase 4 | 545 | Hoffmann-La RocheINDUSTRY | 24 | Aug 14, 2017 | clinicaltrials |
| NCT01639703 | Hepatic Xenetix-CT Perfusion | completed | Phase 4 | 96 | GuerbetINDUSTRY | 4 | Jul 13, 2017 | clinicaltrials |
| NCT00329602 | Long-term Study Of Ropinirole In Restless Legs Syndrome | completed | Phase 4 | 404 | GlaxoSmithKlineINDUSTRY | 11 | Mar 23, 2017 | clinicaltrials |
| NCT01061177 | Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome & /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase('MACS1252) | completed | Phase 4 | 1,090 | Novartis PharmaceuticalsINDUSTRY | 26 | Feb 24, 2017 | clinicaltrials |
| NCT01203917 | Efficacy, Safety, Tolerability of Gefitinib as 1st Line in Caucasian Patients With EGFR Mutation Positive Advanced NSCLC(IFUM) | completed | Phase 4 | 1,060 | AstraZenecaINDUSTRY | 13 | Jan 2, 2017 | clinicaltrials |
| NCT00949910 | An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 4 | 6,586 | Hoffmann-La RocheINDUSTRY | 51 | Oct 5, 2016 | clinicaltrials |
| NCT00451906 | A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer. | completed | Phase 4 | 2,252 | Hoffmann-La RocheINDUSTRY | 40 | May 24, 2016 | clinicaltrials |
| NCT02246023 | Fractionated Versus Target-controlled Propofol Administration in Bronchoscopy | completed | Phase 4 | 78 | Daniel FranzenOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT01402089 | Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients | completed | Phase 4 | 54 | Markus JoergerOTHER | 1 | Feb 2, 2016 | clinicaltrials |
| NCT01641458 | Pharmacology-driven Dosing of Fluoropyrimidines in Cancer Patients(FLOXTOX2) | completed | Phase 4 | 37 | Cantonal Hospital of St. GallenOTHER | 1 | Feb 2, 2016 | clinicaltrials |
| NCT02612870 | Sienna+® Injection Time Study 4 Arms(Sentimag02) | unknown | Phase 4 | 40 | Kantonsspital BadenOTHER | 1 | Nov 24, 2015 | clinicaltrials |
| NCT02490059 | Ultrathin Bronchoscopy for Solitary Pulmonary Nodules(Babyscope) | completed | Phase 4 | 40 | University of ZurichOTHER | 1 | Jul 3, 2015 | clinicaltrials |
| NCT01950871 | Prostate Guided Biopsy Study Evaluating the Diagnostic Performance of Prostate HistoScanning(PHSTT-01) | terminated | Phase 4 | 80 | Advanced Medical Diagnostics s.a.INDUSTRY | 18 | Jan 5, 2015 | clinicaltrials |
| NCT00764621 | Health Economic Evaluation of Primovist-enhanced Liver MRI | completed | Phase 4 | 360 | BayerINDUSTRY | 9 | Nov 4, 2014 | clinicaltrials |
| NCT00512265 | Influence of N-Acetylcysteine on Morbidity, Oxygenation and Cytokine Levels in Partial or Total Esophagectomy for Cancer | completed | Phase 4 | 29 | University Hospital, Basel, SwitzerlandOTHER | 1 | Aug 28, 2013 | clinicaltrials |
| NCT00492895 | Photosensitivity of the Skin Under Azathioprin in Renal Transplant Recipients | completed | Phase 4 | 25 | University of ZurichOTHER | 1 | Jan 29, 2013 | clinicaltrials |
| NCT01022905 | Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients | completed | Phase 4 | 1,141 | University Hospital, GenevaOTHER | 1 | Mar 1, 2010 | clinicaltrials |
| NCT00143312 | Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants(VOSIFI) | completed | Phase 4 | 45 | PfizerINDUSTRY | 8 | Oct 6, 2009 | clinicaltrials |
| NCT00050999 | Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients | completed | Phase 4 | 195 | Eisai Inc.INDUSTRY | 10 | Mar 5, 2008 | clinicaltrials |
| NCT00051012 | Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients | completed | Phase 4 | 86 | Eisai Inc.INDUSTRY | 9 | Mar 5, 2008 | clinicaltrials |
Data updated 4 days agoSource updated unknownsource: clinicaltrials